SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-199180
Filing Date
2023-07-31
Accepted
2023-07-31 16:38:58
Documents
12
Period of Report
2023-07-31
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K d473618d8k.htm   iXBRL 8-K 23907
  Complete submission text file 0001193125-23-199180.txt   148892

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA tars-20230731.xsd EX-101.SCH 2842
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE tars-20230731_lab.xml EX-101.LAB 18738
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tars-20230731_pre.xml EX-101.PRE 11702
6 EXTRACTED XBRL INSTANCE DOCUMENT d473618d8k_htm.xml XML 3477
Mailing Address 15440 LAGUNA CANYON ROAD IRVINE CA 92618
Business Address 15440 LAGUNA CANYON ROAD IRVINE CA 92618 (949) 409-9820
Tarsus Pharmaceuticals, Inc. (Filer) CIK: 0001819790 (see all company filings)

IRS No.: 814717861 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39614 | Film No.: 231127861
SIC: 2836 Biological Products, (No Diagnostic Substances)